Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 34 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2005Phase II study of prolonged ambulatory infusion carboplatin and oral etoposide for patients progressing through hormonal therapy for prostate cancerOlver, I.; Keefe, D.; Myers, M.
2006Catheter Ablation of Long-Lasting Persistent Atrial Fibrillation: Clinical Outcome and Mechanisms of Subsequent Arrhythmias - Reply to the editorHaissaguerre, M.; Jais, P.; Hocini, M.; O'Neill, M.; Sanders, P.
2009Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancerSmit, E.; Burgers, S.; Biesma, B.; Smit, H.; Eppinga, P.; Dingemans, A.; Joerger, M.; Schellens, J.; Vincent, A.; van Zandwijk, N.; Groen, H.
2009Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disordersCollins, J.; Farrall, E.; Turnbull, D.; Hetzel, D.; Holtmann, G.; Andrews, J.
2000A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancerOlver, I.; Stephenson, J.; Schulze, D.
2004Bisphosphonate infusions: patient preference, safety and clinic useChern, B.; Joseph, D.; Joshua, D.; Pittman, K.; Richardson, G.; Schou, M.; Lowe, S.; Copeman, M.; De Abreu Lourenco, R.; Lynch, K.
2007A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitisKahrilas, P.; Dent, J.; Lauritsen, K.; Malfertheiner, P.; Denison, H.; Franzen, S.; Hasselgren, G.
2007Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug useProudman, S.; Keen, H.; Stamp, L.; Lee, A.; Goldblatt, F.; Ayres, O.; Rischmueller, M.; James, M.; Hill, C.; Caughey, G.; Cleland, L.
2000Long-term omeprazole treatment in resistant gastroesophageal reflux disease: Efficacy, safety, and influence on gastric mucosaKlinkenberg-Knol, E.; Nelis, F.; Dent, J.; Snel, P.; Mitchell, B.; Prichard, P.; Lloyd, D.; Havu, N.; Frame, M.; Roman, J.; Walan, A.
2006Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexateMurphy, N.; Diviney, M.; Szer, J.; Bardy, P.; Grigg, A.; Hoyt, R.; King, B.; MacGregor, L.; Holdsworth, R.; McCluskey, J.; Tait, B.